Results 271 to 280 of about 18,220 (284)

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Journal of Allergy and Clinical Immunology, 2013
Allen P Kaplan, Janice Canvin, Piotr Kuna   +2 more
exaly  

Chronic Urticaria

New England Journal of Medicine, 2022
exaly  

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria

Journal of Allergy and Clinical Immunology, 2016
Allen P Kaplan, Marta Ferrer, Karina Raimundo   +2 more
exaly  

Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

Allergy: European Journal of Allergy and Clinical Immunology, 2019
Ricardo Asero, Marta Ferrer, Ana Gimenez-Arnau   +2 more
exaly  

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Lancet, The
Gordon Sussman, Sarbjit Saini, Clive E Grattan   +2 more
exaly  

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Marcus Maurer
exaly  

Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials

Journal of Allergy and Clinical Immunology, 2016
Tomasz Hawro, Marcus Maurer
exaly  

Metformin-Induced Acute Urticaria Mimicking Chronic Spontaneous Urticaria

Dermatitis®
Nerea Manzanares, David Pesqué, Ramon M. Pujol, Ana M. Giménez-Arnau   +3 more
openaire   +1 more source

Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment

Lancet, The
Clive E Grattan, Emek Kocatürk, P V Kolkhir   +2 more
exaly  

Comparative efficacy of ligelizumab versus omalizumab in chronic spontaneous urticaria

Lancet, The
Elena Netchiporouk
exaly